Benzinga's Volume Movers

surged 19.06% to $14.18. The volume of Vanda Pharmaceuticals shares traded 952% higher than normal. Vanda Pharmaceuticals announced its plans to acquire rights to Phase II clinical compound from

. Novartis will purchase $25 million of Vanda common stock.

shares climbed 5.87% to $11.00. The volume of CryoLife shares traded was 196% higher than normal. Analysts at Piper Jaffray upgraded CryoLife from Neutral to Overweight and raised the price target from $10 to $15.

shares rose 0.91% to $50.80. The volume of Solera Holdings shares traded was 113% higher than normal. Solera's PEG ratio is 1.26.

shares moved up 3.76% to $60.18. The volume of GoPro traded was 105% higher than normal. GoPro shares surged amid a positive research note from Wedbush.